Literature DB >> 14992989

Absence of histological lesions in primate models of ECT and magnetic seizure therapy.

Andrew J Dwork1, Victoria Arango, Mark Underwood, Boro Ilievski, Gorazd Rosoklija, Harold A Sackeim, Sarah H Lisanby.   

Abstract

OBJECTIVE: The authors present preliminary findings from the first nonhuman primate neuropathological study of ECT to use perfusion fixation and adequate controls and the first to compare ECT with magnetic seizure therapy, to their knowledge.
METHOD: Twelve Macaca mullata received 6 weeks of daily ECT, magnetic seizure therapy, or anesthesia alone. After perfusion fixation, their brains were examined while masked to intervention.
RESULTS: No identified lesions were attributable to the interventions. Cortical and hippocampal immunoreactivity for glial fibrillary acidic protein (an astrocytic marker) was most intense in the group that received ECT.
CONCLUSIONS: This small but rigorous primate study supports the view that ECT does not produce histological lesions in the brain and provides the first comparable safety data on magnetic seizure therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992989     DOI: 10.1176/appi.ajp.161.3.576

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  23 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

Review 2.  Brain stimulation in psychiatry and its effects on cognition.

Authors:  Kate E Hoy; Paul B Fitzgerald
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

3.  What is the role of brain stimulation therapies in the treatment of depression?

Authors:  Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

4.  A systematic review of the neurocognitive effects of magnetic seizure therapy.

Authors:  Shawn M McClintock; Owais Tirmizi; Matthieu Chansard; Mustafa M Husain
Journal:  Int Rev Psychiatry       Date:  2011-10

5.  Dissociative changes in gray matter volume following electroconvulsive therapy in major depressive disorder: a longitudinal structural magnetic resonance imaging study.

Authors:  Hui Xu; Teng Zhao; Feifei Luo; Yunsong Zheng
Journal:  Neuroradiology       Date:  2019-08-13       Impact factor: 2.804

Review 6.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

7.  Quick recovery of orientation after magnetic seizure therapy for major depressive disorder.

Authors:  George Kirov; Klaus P Ebmeier; Allan I F Scott; Maria Atkins; Najeeb Khalid; Lucy Carrick; Andrew Stanfield; Ronan E O'Carroll; Mustafa M Husain; Sarah H Lisanby
Journal:  Br J Psychiatry       Date:  2008-08       Impact factor: 9.319

8.  Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy.

Authors:  A J Dwork; J R Christensen; K B Larsen; J Scalia; M D Underwood; V Arango; B Pakkenberg; S H Lisanby
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

9.  Structure-related oxidative damage in rat brain after acute and chronic electroshock.

Authors:  T Barichello; F Bonatto; F R Agostinho; A Reinke; J C F Moreira; F Dal-Pizzol; I Izquierdo; J Quevedo
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 10.  Translational development strategy for magnetic seizure therapy.

Authors:  Stefan B Rowny; Karla Benzl; Sarah H Lisanby
Journal:  Exp Neurol       Date:  2009-04-05       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.